Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s share price traded down 29.1% during mid-day trading on Thursday . The company traded as low as $0.2611 and last traded at $0.2611. 300 shares traded hands during trading, a decline of 99% from the average session volume of 20,342 shares. The stock had previously closed at $0.3684.
Cell MedX Stock Down 29.1%
The firm’s 50-day simple moving average is $0.38 and its 200 day simple moving average is $0.35.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Further Reading
- Five stocks we like better than Cell MedX
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- Profitably Trade Stocks at 52-Week Highs
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- Why is the Ex-Dividend Date Significant to Investors?
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
